Creative Planning’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History
Bought
Maintained
Sold
Other funds holding MTRI
SM
Creative Planning's MTRI Position: Q3 2022 in Review
Creative Planning sold out of Mentari Therapeutics, Inc. Common Stock (MTRI) in Q3 2022, closing a stake of 2 shares — an estimated $5K sold.
Creative Planning first reported a position in MTRI in Q4 2020 and held it in 7 quarters. The position peaked at $36K in Q1 2021. 7 funds tracked by Wall St. Rank hold MTRI as of Q3 2022.
- Creative Planning reported no remaining Mentari Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
- Creative Planning sold 2 Mentari Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $5K.
- Creative Planning first reported a position in Mentari Therapeutics, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
- Creative Planning's Mentari Therapeutics, Inc. Common Stock position peaked at $36K in Q1 2021.
- 7 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q3 2022.
Based on Creative Planning's 13F filing for Q3 2022, filed 3 Nov 2022.